Please try another search
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics, as well as non-steroidal anti-inflammatory drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Humayun R. Dhanrajgir | 85 | 2004 | Independent & Non-Executive Director |
Sachin Dinesh Patel | 47 | 2007 | CEO, MD & Executive Director |
Dinesh Shantilal Patel | 75 | 2017 | Executive Chairman |
Reena Sachin Patel | - | 2023 | VP of Systems & Administration and Alternate Non-Executive Non-Independent Director |
Hariharan Subramaniam | 64 | 2014 | Independent Director |
Bhaskar Vemban Iyer | 67 | 2021 | Independent Director |
Rajneesh Kedarnath Anand | 69 | 2007 | Non-Executive Director |
Manjul Sandhu | 58 | 2020 | Additional Independent Woman Director |
Adam Demeter | - | 2023 | Additional Non-Executive Non-Independent Director |
Shishir Vasant Dalal | 68 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review